The Impact of COVID‑19 Disease & Vaccination on Pregnancy and Newborns
Speakers: T Bogler, C Hankins, D Money, D Fell, D O’Connor, & S Unger.
Globally, there are limited data on COVID‑19 illness and vaccination during pregnancy to inform recommendations for pregnant people and their care providers and to guide public health policies. For that reason, the COVID‑19 Immunity Task Force (CITF) and CanCOVID are eager to share the latest research from three CITF-supported studies on the impact of SARS-CoV-2 infection and COVID‑19 vaccination on pregnancy and newborns.
Among the topics to be addressed:
- The increased risk of serious illness requiring hospital admission for pregnant people with a SARS-CoV-2 infection.
- The higher risk of consequences to the baby (e.g. premature birth, low birth weight).
- Results from a recent study on pregnancy outcomes among individuals who received COVID‑19 vaccines during pregnancy, compared with unvaccinated individuals.
- The presence of SARS-CoV-2 antibodies in breastmilk and the value of breastfeeding following infection and vaccination.
The results from these studies are communicated regularly to public health officials to help inform decision-making for ongoing COVID‑19 vaccine administration programs in Canada.
Related Resources
Event
September 14, 2021
Understanding COVID‑19 risk, vaccine confidence, and immunogenicity in the South Asian population in Canada
Speaker: S Anand
Event
June 29, 2021
Increased Use Of Birth Interventions In Response To COVID-19? Findings From A Canada-Wide Qualitative Study
Speaker: K Rice
Event
November 2, 2021
The Shadow Pandemic: Intimate Partner Violence and Brain Injury
Speakers: A Colantonio, D Toccalino, H Haag
Event
January 24, 2022
How Long Does COVID‑19 Immunity Last? Waning Immunity, Boosters, and Dosing Intervals
Speakers: N Muhajarine, T Evans, D Bowdish, A Costa, VH Ferreira, & J Kwong.
